Literature DB >> 2777218

Prognosis of ovarian carcinomas: prediction by histoquantitative methods.

H Haapasalo1, Y Collan, N B Atkin, E Pesonen, A Seppä.   

Abstract

Prediction of prognosis of ovarian carcinomas by morphometric, histopathological and clinical indices was estimated in 105 tumours. Morphometric parameters included mitotic activity index, volume-corrected mitotic index (M/V index), volume fraction of neoplastic epithelium, nuclear area, nuclear perimeter, shortest and longest nuclear axis and form factor of nucleus. Cox's multivariate regression model showed that the clinical stage was the best predictor of prognosis followed by the M/V index, which expresses the mitotic activity as the number of mitotic figures per square millimeter of neoplastic epithelium in the microscope field. In all tumour subgroups studied the M/V index was the best prognostic factor and for stage I tumours it was the only parameter selected by the Cox's model as a significant and independent prognostic predictor. We conclude that the M/V index can be used as a significant prognostic factor in ovarian carcinomas.

Entities:  

Mesh:

Year:  1989        PMID: 2777218     DOI: 10.1111/j.1365-2559.1989.tb03064.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma.

Authors:  M Brinkhuis; J P Baak; G A Meijer; P J van Diest; O Mogensen; P Bichel; J P Neijt
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Mitotic indexes as prognostic predictors in female breast cancer.

Authors:  S Aaltomaa; P Lipponen; M Eskelinen; V M Kosma; S Marin; E Alhava; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.

Authors:  Mark M Aloysius; Shivanthi J De Silva Hewavisenthi; Timothy E Bates; Brian J Rowlands; Dileep N Lobo; Abed M Zaitoun
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

5.  A rapid and simple staining method, using toluidine blue, for analysing mitotic figures in tissue sections.

Authors:  P Chieco; M Pagnoni; E Romagnoli; C Melchiorri
Journal:  Histochem J       Date:  1993-08

6.  Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer.

Authors:  P K Lipponen; M J Eskelinen
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.

Authors:  P K Lipponen; M J Eskelinen; K Jauhiainen; E Harju; P Terho; H Haapasalo
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  The prognostic value of morphometry in advanced epithelial ovarian cancers.

Authors:  M Katsoulis; J Lekka; I Vlachonikolis; G S Delides
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

9.  Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.

Authors:  P K Lipponen; M J Eskelinen
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

10.  Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

Authors:  J M Karjalainen; M J Eskelinen; S Nordling; P K Lipponen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.